0 - ฿0.00

No products in the cart.

In Stock

Immunophenotyping for Minimal Residual Disease for Acute Myeloid Leukemia

฿14,250.00

Additional information

Also Known As

MRD Immunophenotyping for AML

Specimen

1. Heparinized or EDTA bone marrow 5 ml+ 2 slidesof bone marrow smear (Unstain) or 2. Heparinized or EDTA Peripheral blood 5 mL

Turnaround Time

9 days

Test Code

MD-NLA824

Test Type

Special

Detects minimal residual disease in acute myeloid leukemia (AML) after treatment.

Diseases: Blood Cancers
Habits: None
Age Groups: All Ages
Specimens: Blood, Bone Marrow
Diagnostic Methods: Flow Cytometry
ADD AND CHECKOUT

Description

Detects minimal residual disease in acute myeloid leukemia (AML) after treatment.

This lab test includes home sample collection via a provided kit or by a clinician, and you'll receive a comprehensive physical health report with your results.

Additional information

Also Known As

MRD Immunophenotyping for AML

Specimen

1. Heparinized or EDTA bone marrow 5 ml+ 2 slidesof bone marrow smear (Unstain) or 2. Heparinized or EDTA Peripheral blood 5 mL

Turnaround Time

9 days

Test Code

MD-NLA824

Test Type

Special